Based in the UK, Stirling Anglian is committed to medicines optimisation. It has sourced and developed a portfolio of medicines to help the NHS curb waste - across a range of conditions that currently place unnecessary and avoidable pressure on NHS resources. At a time when there is such pressure on the NHS to reduce costs we believe we offer a real and practical solution.
We work closely with stakeholders across the NHS to identify real-world problems, and develop value-based solutions that support the delivery of efficient and cost-effective healthcare.
We work closely with stakeholders across the NHS to identify real-world problems, and develop value-based solutions that support the delivery of efficient and cost-effective healthcare.
Services
Our brand portfolio - and our product pipeline - focuses on areas of identified need and high wastage1. Each promises significant savings to NHS organisations - and thus potential improvements to patient care. CosmoCol powder for oral solution is an osmotic laxative indicated for the treatment of chronic constipation and for the resolution of faecal impaction.
Stirling Anglian Pharmaceuticals places the highest importance on patient safety. Our pharmacovigilance infrastructure reflects this, ensuring that we remain compliant with reporting requirements and flexible to future needs and trends. Our pharmacovigilance (PV) team is based at Jenson R+ offices, and works closely with Stirling Anglian staff to manage the important links and information flow into our central team.
Reviews
Be the first to review Stirling Anglian Pharmaceuticals.
Write a Review
